CAPR (STOCKS)
Capricor Therapeutics Inc
$24.200000
-0.430000 (-1.75%)
Prev close: $24.630000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Linda Marbán
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,315.96M
- Employees
- 160
- P/E (TTM)
- -13.69
- P/B (TTM)
- 13.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $11.13M |
| Nonoperating Income/Loss | $4.69M |
| Operating Expenses | $97.81M |
| Research and Development | $75.88M |
| Other Operating Expenses | $21.94M |
| Operating Income/Loss | -$86.68M |
| Income/Loss From Continuing Operations After Tax | -$81.99M |
| Income/Loss From Continuing Operations Before Tax | -$81.99M |
| Net Income/Loss | -$81.99M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$81.99M |
| Net Income/Loss Available To Common Stockholders, Basic | -$81.99M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.75 |
| Diluted Earnings Per Share | -$1.75 |
| Basic Average Shares | 94,508,673 |
| Diluted Average Shares | 94,508,673 |
| Assets | $126.44M |
| Current Assets | $100.95M |
| Cash | $98.60M |
| Other Current Assets | $2.35M |
| Noncurrent Assets | $25.49M |
| Fixed Assets | $11.07M |
| Other Non-current Assets | $14.42M |
| Liabilities | $42.57M |
| Current Liabilities | $28.15M |
| Accounts Payable | $2.72M |
| Wages | $4.73M |
| Other Current Liabilities | $20.70M |
| Noncurrent Liabilities | $14.42M |
| Equity | $83.87M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $83.87M |
| Liabilities And Equity | $126.44M |
| Net Cash Flow From Operating Activities | -$61.04M |
| Net Cash Flow From Operating Activities, Continuing | -$61.04M |
| Net Cash Flow From Investing Activities | -$68.99M |
| Net Cash Flow From Investing Activities, Continuing | -$68.99M |
| Net Cash Flow From Financing Activities | $81.16M |
| Net Cash Flow From Financing Activities, Continuing | $81.16M |
| Net Cash Flow | -$48.87M |
| Net Cash Flow, Continuing | -$48.87M |
| Comprehensive Income/Loss | -$81.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$81.24M |
| Other Comprehensive Income/Loss | -$24.18M |